MAGED1 (melanoma-associated antigen D1) is a type II MAGE family protein that functions as a multifaceted regulator of neuronal development, apoptosis, and transcriptional processes 1. The protein plays critical roles in the central nervous system, regulating apoptotic responses and synaptic transmission through interactions with transcription factors like CREB 2. MAGED1 acts as a selective regulator of specific bHLH PAS transcription factors including SIM1, SIM2, NPAS4, and ARNT2, enhancing their function through cytoplasmic interactions prior to nuclear import 3. In epigenetic regulation, MAGED1 partners with USP7 to control H2A monoubiquitination in the paraventricular thalamus, influencing cocaine-adaptive behaviors and transcriptional repression 4. The protein demonstrates tumor suppressor properties, with downregulation observed in various cancers including colorectal carcinoma, where reduced expression correlates with advanced disease stage and poor prognosis 5. MAGED1 deficiency results in neurocognitive deficits, impaired learning and memory formation, and altered synaptic plasticity 2. Interestingly, MAGED1 loss provides neuroprotection in Parkinson's disease models by upregulating Akt signaling and enhancing autophagy 6. Clinical relevance includes association with X-linked intellectual disability syndromes when deleted alongside neighboring genes 7.